‘표준치료를 받은 폐암 환자의 한방병원 입원 임상경로’개발 및 적용
Developed and Implemented a Clinical Pathway for Lung Cancer Patients Admitted to Korean Medicine Hospital after Standard Treatment
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
The objective of this study was to develop a critical pathway of integrative medicine to improve the quality of life of lung cancer patients who received standard western medicine treatments. A total of 10 medical professionals, including western and Korean medicine doctors, and nurses participated in a validation survey and revised clinical pathway. Then we applied the critical pathway to 11 lung cancer patients who admitted at Korean medicine hospital and evaluated quality of life at the beginning and discharge of admission using European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire(EORTC QLQ). More than 80% of the respondents gave a score of 3 (appropriate) or more for all items in the validation survey and we modified the clinical pathway by adding ‘bed rest’to the activity item. When applying the revised critical pathway to 11 lung cancer patients, the score of 'Nausea and vomiting', 'Insomnia' in EORTC QLQ-30 and ‘chest pain’in EORTC LC-13 showed statistically significant improvements in the before-and-after admission comparision. The application of revised inpatient critical pathway of integrative medicine for lung cancer showed improvement in some symptoms. Development of more critical pathway in various clinical setting and larger scaled application studies of critical pathway are needed.
Abstract
The objective of this study was to develop a critical pathway of integrative medicine to improve the quality of life of lung cancer patients who received standard western medicine treatments. A total of 10 medical professionals, including western and Korean medicine doctors, and nurses participated in a validation survey and revised clinical pathway. Then we applied the critical pathway to 11 lung cancer patients who admitted at Korean medicine hospital and evaluated quality of life at the beginning and discharge of admission using European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire(EORTC QLQ). More than 80% of the respondents gave a score of 3 (appropriate) or more for all items in the validation survey and we modified the clinical pathway by adding ‘bed rest’to the activity item. When applying the revised critical pathway to 11 lung cancer patients, the score of 'Nausea and vomiting', 'Insomnia' in EORTC QLQ-30 and ‘chest pain’in EORTC LC-13 showed statistically significant improvements in the before-and-after admission comparision. The application of revised inpatient critical pathway of integrative medicine for lung cancer showed improvement in some symptoms. Development of more critical pathway in various clinical setting and larger scaled application studies of critical pathway are needed.
참고문헌 (32)
- "Annual report of cancer statistics in Korea in 2020" (2023)[URL]
- 장승훈, "국가 폐암 검진", 대한내과학회지, 95(2), pp.95~103 (2020), 대한내과학회[DOI]
- Kim SD, "Evaluation of Radon Exhalation Rate from Concrete Surface with Paint", J Architectural institute of Korea, 43(1), pp.849~ (2023)
- 정한진, "미세먼지가 알레르기비염에 미치는 영향과 기전", 대한이비인후-두경부외과학회지, 66(2), pp.75~84 (2023), 대한이비인후과학회[DOI]
- 김정선, "비소세포폐암의 표적 치료", 대한내과학회지, 95(2), pp.78~88 (2020), 대한내과학회[DOI]
- Win T, "Effect of lung cancer surgery on quality of life", Thorax, 60(3), pp.234~238 (2005)
- Korean Association for Lung Cancer, "Ask me anything about lung cancer", pp.106~ (2001), YD&P
- Jeng HC, "Principles of cancer drug therapy and managing common side effects", Korean J Med. Autumn Conference Proceedings, (2), pp.119~128 (2014)
- 장윤수, "Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma", Tuberculosis and Respiratory Diseases, 79(4), pp.248~256 (2016), 대한결핵및호흡기학회
- Jang SH, "Adeverse Events of Immune Checkpoint Inhibitors", Pharmacoepidemiology and Risk Management, 11(1), pp.15~20 (2019)
- 오인옥, "국내 의료기관의 표준진료지침 개발 및 운영 현황", 한국의료질향상학회지, 28(1), pp.2~13 (2022), 한국의료질향상학회[DOI]
- Konishi T, "Significance of critical path for gastric cancer: Gastrointestinal diseases and social medicine", Nippon Shokakibyo Gakkai Zasshi, 98(12), pp.1341~1348 (2001)
- 홍미나, "‘항암화학요법을 받은 폐암 환자의 예비 통합의학 임상경로’ 개발 및 타당도 평가", 대한한방내과학회지, 38(6), pp.917~929 (2017), 대한한방내과학회
- Kwon HK, "Review for the Status of Cancer Complementary and Alternative Medicine in the World", J Korean Tradit Oncol, 14(1), pp.1~11 (2009)
- Menzies AM, "Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab", Ann Oncol, 28, pp.368~376 (2017)
- 정현정, "폐암 환자의 치료 및 관리에서 한의학적 치료의 역할", 대한암한의학회지, 20(1), pp.45~54 (2015), 대한암한의학회
- Yoo SH, "A Case Report for Recurred Squeamous Cell Lung Carcinoma Treated with Hang-An-Dan : 7-year follow-up", Korean J Int Korean Med, 28(2), pp.385~390 (2007)
- 정홍매, "진행성 비소세포성 폐암환자에 대한 항암플러스의 치료효능: 연속증례보고", 대한한방내과학회지, 32(1), pp.113~120 (2011), 대한한방내과학회
- Song SY, "Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer", Integr Cancer Ther, 21 (2022)
- Li YX, "Current Status and Prospects of TCM Maintenance Therapy in Treating Advanced NSCLC", Information on TCM, 37(4), pp.126~129 (2020)
- 김명화, "Utilization of Complementary and Alternative Medicine of Cancer Patient in Korea", 농촌의학.지역보건, 32(3), pp.155~167 (2007), 한국농촌의학.지역보건학회
- 장순복, "우리나라 암환자가 이용하는 보완대체요법에 관한 연구", 성인간호학회지, 18(1), pp.92~101 (2006), 한국성인간호학회
- Wu FK, "Determinants of Complementary and Alternative Medicine use among Lung Cancer patients in Shandong Province", Master, pp.2023
- Jeong GS, "Experiences and attitudes of lung cancer patients receiving complementary and alternative therapies", Master, pp.2006
- Iwase S, "The clinical use of Kampomedicines(traditional Japanese herbal treatments)for controlling cancer patients' symptoms in Japan : a national cross-sectional survey", BMC Complement Altern Med, 12, pp.222~ (2012)
- 김도형, "폐암 환자에 대한 부가적인 침치료 효과 - 단일군, 전후, 예비임상 연구 -", 동의생리병리학회지, 28(1), pp.82~88 (2014), 한의병리학회
- 성연실, "내관(P6) 지압이 항암화학요법을 받는 폐암 환자의 오심과 구토,식욕부진에 미치는 영향", 동서간호학연구지, 16(1), pp.1~10 (2010), 동서간호학연구소
- Wang YL, "Effect of acupuncture in different time on nausea and vomiting induced by chemotherapy of lung cancer", Zhongguo Zhen jiu, 39(12), pp.1269~1273 (2019)
- 장순양, "지압이 항암요법환자의 오심과 구토에 미치는 효과 관련 연구 분석", Asian Oncology Nursing, 11(2), pp.116~126 (2011), 대한종양간호학회
- Romero SAD, "What makes one respond to acupuncture for insomnia Perspectives of cancer survivors", Palliat Support Care, 18(3), pp.301~306 (2020)
- Ye T, "Observation on the application effect of acupressure care in patients with insomnia undergoing chemotherapy for lung cancer", Proceedings of 2019 Shanghai International Nursing Conference, pp.790~ (2019)
- Li J, "The effect of Supplementing Qi and nourishing Yin combined with chemotherapy for lung cancer : a meta-analysis", TMR Integrative Medicine, 1(2), pp.45~54 (2018)